ArticleDrug design, development and therapy2022

Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China.

Xiao-Qi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.